Floxadil® 100 mg/ml

Solution for injection

Composition

Enrofloxacin 100 mg – Excipients q.s. ad 1 ml.

Pharmacotherapeutic category

Antibacterial for systemic use (fluoroquinolones).

Properties

Enrofloxacin acts by inhibition of bacterial DNA gyrase resulting in inhibition of DNA and mRNA synthesis. It has a concentration-dependent bactericidal action against Gram-negative bacteria, Gram-positive bacteria and mycoplasmas.

Indications

For the treatment of infections caused by enrofloxacin susceptible microorganisms, such as:

  • Cattle: infections of the respiratory tract (P. multocida, M. haemolytica, Mycoplasma spp.), the digestive tract (E. coli), septicaemia (E. coli), acute arthritis (Mycoplasma bovis), mastitis (E. coli).
  • Pigs: infections of the respiratory tract (P. multocida, A. pleuropneumoniae, Mycoplasma spp.), the digestive tract (E. coli), septicaemia (E. coli), the urinary tract (E. coli), MMA (E. coli, Klebsiella spp.).

Dosage, route and method of administration

IV, IM or SC injection: 2.5 – 5 mg enrofloxacin per kg BW (0.5 – 1 ml/20 kg BW), once daily for 2 to 5 days (Administration route, daily dose and duration depend on animal species & indication).

Shelf-life

3 years.

Packaging

Vials of 100 or 250 ml.
Carton with 1, 6 or 12 vials.



The trade name and/or the specifications of the product (target animal species, indications, dosage and administration, precautions and warnings, etc.) may differ from country to country. Please contact us for further information.